Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Aug 14Aug 14
Quote
Day Range
$109.04 – $116.45
52-Week Range
$20.31 – $116.47
Volume
$830.2K
Market Cap
$6.49B
50-Day Avg
$97.22
200-Day Avg
$70.44
Prev Close
$109.60
Open
$109.08
Valuation & Ratios
P/E Ratio
-9.81
EPS
$-4.30
P/B Ratio
3.16
P/S Ratio
764.98
Debt/Equity
0.00
Current Ratio
13.32
Dividend Yield
+0.0%
Gross Margin
+100.0%
Returns & Efficiency
Return on Equity
-32.9%
Return on Assets
-30.6%
FCF Yield
-8.3%
EV/EBITDA
-9.31
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.04M | $-162.34M | $-4.20 |
| 2024 | $6.24M | $-84.97M | $-2.55 |
| 2023 | $2.83M | $-43.55M | $-8.45 |
| 2022 | $6.42M | $-28.48M | $-7.60 |
| 2021 | $1.48M | $-13.11M | $-3.82 |
Social Signal Score
50
5d
50
1 mentions
—
30d
50
1 mentions
—
60d
50
1 mentions
—
90d
50
1 mentions
—
rss: 1
Earnings
Wed, Nov 4(in 3 months)
Consensus estimate $-1.02 per share
3of 7 quarters beat consensus
Typical surprise -2.3% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$-0.90 vs $-0.85miss
- Tue, May 5$-0.85 vs $-1.17beat
- Mon, Mar 9$-1.43 vs $-0.98miss
- Wed, Nov 5$-0.97 vs $-0.86miss
- Thu, Aug 7$-0.88 vs $-0.86miss
- Mon, May 12$-0.82 vs $-0.86beat
Estimates and results for DNTH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
DNTHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- News (RSS)investing·22h ago·Neutral
Dianthus Therapeutics stock hits 52-week high at 114.64 USD
View source ↗